Stock Analysis · NASDAQ: NIVF · Updated October 1, 2026

NIVF Stock Price Prediction: The Bull Case for NewGenIvf Group Limited

A speculative NIVF price prediction for NewGenIvf Group Limited (NASDAQ: NIVF): the six positive catalysts that could lift the shares, the arithmetic of a move toward $1, and the dilution and volatility risks that sit on the other side of the trade.

NIVF price: $0.1053
Change: -37.32%
Previous close: $0.1680
Day range: $0.0939 – $0.1220
Market cap: ~$0.24M
Revenue (TTM): $4.73M
Shares out: ~2.24M
Float: ~0.93M

Snapshot as of October 1, 2026, 12:58 PM EDT. Not a live quote.

What is NewGenIvf Group Limited (NIVF)?

NewGenIvf Group Limited is an investment holding company that provides assisted reproductive services to couples and individuals seeking fertility treatment, operating through clinics in Thailand, Cambodia, Hong Kong and Kyrgyzstan. Its treatment menu runs from conventional IVF and ICSI through embryo culture, hormonal and infectious-disease testing, chromosome screening, hysteroscopy, sperm analysis and freezing, and egg freezing, supplemented by surrogacy and ancillary caring services and value-added support such as nutrition guidance, psychological counselling, acupuncture and translation. The company is headquartered in Bangkok, Thailand, employs about 87 people, and listed on Nasdaq in March 2022 under the ticker NIVF.

That makes NIVF a three-way bet at once: a Asia-Pacific fertility operator, a diversified healthcare-and-technology holding company with real-estate and digital-asset divisions, and a nano-cap Nasdaq listing where liquidity, not fundamentals, usually sets the daily price.

The bull case

Six reasons NIVF stock could go up

01A market cap smaller than its own revenue

NewGenIvf Group Limited carries a market capitalisation in the low hundreds of thousands of dollars while reporting trailing-twelve-month revenue of about $4.73M. On those numbers the stock trades well below one times sales, a valuation that leaves room for a re-rate if sentiment simply stops deteriorating.

02Real fertility clinics, not a concept

NewGenIvf operates assisted-reproductive-technology clinics in Thailand, Cambodia, Hong Kong and Kyrgyzstan, offering IVF, ICSI, egg freezing, embryo culture, chromosome screening and surrogacy and ancillary caring services. The asset base is physical and revenue-generating.

03Asia-Pacific fertility demand is structural

Declining birth rates, delayed parenthood and rising private-pay access keep pushing demand for IVF across Asia-Pacific. Management's stated mission is widening access to fertility treatment in exactly that region, which is a long-duration tailwind rather than a one-quarter story.

04Medical-tourism economics favour Thailand

Thailand is a global hub for high-quality, lower-cost medical care, and NewGenIvf is headquartered in Bangkok. Clinics that attract international patients can charge Western-comparable treatment fees against a Thai cost base, which is where margin narratives in this sector usually start.

05A diversified platform with optionality

Beyond fertility, NewGenIvf describes itself as operating through divisions spanning real-estate development in Ras Al Khaimah (UAE) and digital-asset and DeFi solutions, and it has signed a share purchase agreement for an initial stake in K25.ai with exclusive Asia-Pacific agency rights. Optionality is cheap when the market cap is this small.

06A tiny float that re-prices fast

With roughly 0.93M shares in the float, even modest buying interest moves the price. That is exactly the mechanic that turns a $0.10 micro-cap into a $1 micro-cap during a sentiment cycle — and the same mechanic that makes the shares violently volatile.

Price prediction

NIVF price prediction: what $1 actually requires

Any NIVF stock price prediction has to start with arithmetic rather than optimism. At a share price near $0.1053 with roughly 2.24M shares outstanding, a $1 NIVF price implies a market capitalisation of only about $2.2M — still smaller than the roughly $4.73M of trailing revenue the company reports. In other words, reaching $1 does not require the business to become large; it requires the market to stop valuing it at a fraction of its sales.

Scenario	NIVF price	Multiple vs today	Implied market cap
Snapshot (October 1, 2026)	$0.1053	—	~$0.24M
Recovery on Q3 results	$0.25	~2.4x	~$0.56M
Liquidity and coverage return	$0.50	~4.8x	~$1.12M
Bull-case re-rating	$1.00	~9.5x	~$2.24M

Implied market caps are illustrative multiples of the current share count. They assume no new issuance, which is a strong assumption — see the dilution risk below. These are hypothetical scenarios, not price targets or forecasts.

Catalysts

What has to go right for NIVF to reach $1

▲Q3 2026 results, expected around October 5, 2026, show clinic throughput and revenue stabilising rather than contracting.
▲The company stops funding itself with deeply discounted equity and warrant packages, so the share count stops expanding under existing holders.
▲A recognised exchange-listed revenue multiple is applied to the existing $4.73M of trailing sales instead of a distressed discount.
▲At least one division — fertility, the Ras Al Khaimah property pipeline, or the K25.ai Asia-Pacific agency agreement — produces a signed, quantified contract.
▲Daily dollar volume and a wider float attract a research desk, an ETF inclusion or a retail flow cycle large enough to move a 0.93M-share float.

The other side

Why this prediction could be wrong

NewGenIvf Group Limited company profile

Divisions, clinics, leadership and history of the company behind the NIVF ticker.

NIVF stock forecast 2026

Bear, base and bull scenarios for NIVF with the catalyst calendar behind each.

Is NIVF a good investment?

The bull and bear arguments set side by side, plus who this stock actually suits.

Best penny stocks to buy today

Screen results and watchlist names trading under $5 right now.

Sources & further reading

Disclaimer: This page is speculative opinion and independent commentary, not financial advice, a recommendation, a solicitation, or an offer to buy or sell any security. Every price target and scenario shown here is a hypothetical illustration, not a forecast or a guarantee. NewGenIvf Group Limited (NASDAQ: NIVF) and all other penny stocks mentioned are extremely high-risk: they can and do go to zero, and reverse splits, dilution and delisting are common. Quoted prices are point-in-time snapshots, not live quotes, and may be stale. Always do your own research and consult a licensed financial advisor before investing.